Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-15-039636
Filing Date
2015-05-06
Accepted
2015-05-06 20:18:54
Documents
2
Period of Report
2015-05-06

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 10730
2 EX-24 DOCUMENT attachment1.htm EX-24 4469
  Complete submission text file 0001209191-15-039636.txt   16553
Mailing Address C/O CARDINAL HEALTH PARTNERS 221 NASSAU STREET PRINCETON NJ 08542
Business Address
CLARKE JOHN K (Reporting) CIK: 0001219015 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37378 | Film No.: 15838958

Mailing Address 3545 JOHN HOPKINS COURT, STE #250 SAN DIEGO CA 92121
Business Address 3545 JOHN HOPKINS COURT, STE #250 SAN DIEGO CA 92121 858-731-8389
aTYR PHARMA INC (Issuer) CIK: 0001339970 (see all company filings)

EIN.: 203435077 | State of Incorp.: DE
SIC: 2836 Biological Products, (No Diagnostic Substances)